Insulin Resistance
A metabolic state in which cells respond poorly to insulin, requiring the pancreas to produce progressively higher amounts to maintain normal blood glucose. Insulin resistance is a precursor to type 2 diabetes, is strongly associated with obesity, and accelerates aging through chronic inflammation and metabolic dysfunction.
Insulin resistance is a condition in which the body’s cells — particularly muscle, liver, and adipose tissue — become less responsive to insulin’s signaling. Insulin is the hormone that facilitates glucose uptake from the bloodstream into cells for energy production. When cells resist insulin’s signal, the pancreatic beta cells compensate by secreting more insulin (hyperinsulinemia) to force glucose into cells. Over time, this compensatory mechanism can fail, leading to persistent hyperglycemia and diabetes mellitus.
How Insulin Resistance Develops
Several factors contribute to insulin resistance in dogs:
- Obesity: The strongest risk factor. Adipose tissue, especially visceral fat, secretes inflammatory cytokines (TNF-alpha, IL-6) that directly impair insulin signaling pathways. The Purina Lifetime Study demonstrated that lean-fed dogs lived 1.8 years longer and had lower insulin levels throughout life compared to overweight dogs.
- Cushing’s disease (hyperadrenocorticism): Excess cortisol directly antagonizes insulin action and is a common cause of secondary diabetes in dogs.
- Hypothyroidism: Reduced thyroid hormone impairs metabolic rate and can contribute to insulin resistance.
- Chronic pancreatitis: Repeated pancreatic inflammation can damage beta cells and alter insulin dynamics.
- Age: Aging itself is associated with declining insulin sensitivity, potentially through mitochondrial dysfunction and accumulated cellular damage.
- Medications: Glucocorticoids and progestins directly induce insulin resistance.
Detection
Insulin resistance is not routinely screened for in dogs with the same standardized protocols used in human medicine. Clinical indicators include:
- Persistent fasting hyperglycemia (blood glucose >120 mg/dL)
- Elevated fasting insulin levels
- Obesity (body condition score 7-9/9)
- Glucose intolerance on challenge testing
- Concurrent endocrine disease (Cushing’s, hypothyroidism)
Insulin Resistance and Aging
Insulin and IGF-1 signaling are central nodes in the biology of aging. Research across multiple species shows that reduced insulin/IGF-1 signaling extends lifespan. This is part of why caloric restriction extends lifespan — it lowers circulating insulin and IGF-1. The relationship between body size and lifespan in dogs (small dogs live longer than large dogs) is partly mediated by IGF-1 levels, which affect both growth and insulin sensitivity.
Management
Addressing insulin resistance in dogs centers on:
- Weight management: Returning to ideal body condition (BCS 4-5/9) is the single most effective intervention
- Caloric control: Measured feeding, no free-feeding, caloric targets based on ideal weight
- Exercise: Regular physical activity improves insulin sensitivity independent of weight loss
- Treating underlying endocrine disease: Managing Cushing’s or hypothyroidism can restore insulin sensitivity
- Dietary composition: Higher protein, moderate fat, controlled carbohydrate diets may improve glycemic control